Neoadjuvant chemotherapy for soft tissue sarcoma

被引：0

作者：

Wöll E. ^{[1
]}

机构：

[1] St. Vinzenz Hospital, Zams Sanatoriumstr. 43, Zams

来源：

memo - Magazine of European Medical Oncology | 2014年 / 7卷 / 3期

关键词：

Doxorubicin; Gemcitabibne; Ifosfamide; Neoadjuvant chemotherapy; Soft tissue sarcoma; Taxanes; Trabectedin;

D O I：

10.1007/s12254-014-0170-8

中图分类号：

学科分类号：

摘要：

Soft tissue sarcoma is a rare and very heterogeneous disease. The prognosis of these cancers is mainly influenced by histological grading size location and type of histology. Many aspects argue in favor of neoadjuvant chemotherapy but no singular trial could unambiguously prove an advantage of neoadjuvant therapy. This short review has a focus on neoadjuvant chemotherapy as induction therapy prior to chemoradiation or neoadjuvant chemotherapy alone. © 2014 Springer-Verlag Wien.

引用

页码：169 / 171

页数：2

共 50 条

[31] Soft Tissue Sarcoma
Demetri, George D.
Antonia, Scott
Benjamin, Robert S.
Bui, Marilyn M.
Casper, Ephraim S.
Conrad, Ernest U., III
DeLaney, Thomas F.
Ganjoo, Kristen N.
Heslin, Martin J.
Hutchinson, Raymond J.
Kane, John M., III
Letson, G. Douglas
McGarry, Sean V.
O'Donnell, Richard J.
Paz, I. Benjamin
Pfeifer, John D.
Pollock, Raphael E.
Randall, R. Lor
Riedel, Richard F.
Schupak, Karen D.
Schwartz, Herbert S.
Thornton, Katherine
von Mehren, Margaret
Wayne, Jeffrey
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (06): : 630 - 674
[32] Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
Chan, Abigail S.
Ng, Vincent
Snider, James
Kallen, Michael E.
Miller, Kenneth D.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
[33] Novel Therapeutics in Soft Tissue Sarcoma
Mavroeidis, Leonidas
Napolitano, Andrea
Huang, Paul
Jones, Robin L.
CANCERS, 2025, 17 (01)
[34] Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma
Graham, Danielle S.
van Dams, Ritchell
Jackson, Nicholas J.
Onyshchenko, Mykola
Eckardt, Mark A.
DiPardo, Benjamin J.
Nelson, Scott D.
Chmielowski, Bartosz
Shabason, Jacob E.
Singh, Arun S.
Eilber, Fritz C.
Kalbasi, Anusha
CANCERS, 2020, 12 (09) : 1 - 13
[35] PREOPERATIVE CHEMOTHERAPY IN SOFT-TISSUE SARCOMA MANAGEMENT
ROSEN, G
EILBER, F
ECKARDT, J
HOLMES, C
FORSCHER, CA
LOWENBRAUN, S
SELCH, M
FU, YS
CHIRURG, 1993, 64 (06): : 443 - 448
[36] Contrast-Enhanced Sonography for Monitoring Neoadjuvant Chemotherapy in Soft Tissue Sarcomas
Gulati, Mittul
Hu, James S.
Desai, Bhushan
Hwang, Darryl H.
Grant, Edward G.
Duddalwar, Vinay A.
JOURNAL OF ULTRASOUND IN MEDICINE, 2015, 34 (08) : 1489 - 1499
[37] The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
Ni, Ying
Dong, Yabing
Jiang, Aijun
Zhang, Qun
Wang, Zhantong
Liang, Hui
Zhang, Wei
DISCOVER ONCOLOGY, 2024, 15 (01)
[38] Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy
John Charlson
Current Treatment Options in Oncology, 2018, 19
[39] Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines
Italiano, A.
Toulmonde, M.
Bui-Nguyen, B.
BULLETIN DU CANCER, 2010, 97 (06) : 679 - 686
[40] Emerging therapies for adult soft tissue sarcoma
Radaelli, Stefano
Stacchiotti, Sivia
Casali, Paolo G.
Gronchi, Alessandro
EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (06) : 689 - 704

← 1 2 3 4 5 →